Response to COVID-19

Since the world first learned of a new coronavirus infection, HudsonAlpha Institute for Biotechnology Faculty Investigators and Associate Companies that call the biotech campus home have pivoted some of their efforts to battle the new invisible enemy, COVID-19.


The ability to quickly and accurately detect SARS-CoV-2, the virus that causes COVID-19 disease, is vitally important not only to treat, isolate, or hospitalize infected individuals but also to monitor and track how the virus is spreading within a community.

At the outset of the COVID-19 pandemic, companies residing on HudsonAlpha’s biotech campus increased laboratory testing capacity and launched point-of-care testing diagnostics.


While the ultimate tool for eradicating a new virus is a viral vaccine, vaccine development takes a lot of time. Developing treatments to reduce or alleviate symptoms of the virus is equally important on the road to eradicating SARS-CoV-2.

Several HudsonAlpha Faculty Investigators and Associate Companies on the biotech campus are working tirelessly to produce neutralizing monoclonal antibodies to treat COVID-19 disease symptoms by blocking its viral entry into our cells.


Why do some people get really sick and others don’t? Can we test a person’s blood and determine if they have been infected by or have immunity to SARS-CoV-2? These are the type of questions that HudsonAlpha Faculty Investigators and Associate Companies are trying to answer using their genetic sequencing expertise.

Through a project led by the Centers for Disease Control and Prevention, HudsonAlpha is also sequencing the viral genome from people who have been affected by the disease in an effort to monitor the spread and mutation of the virus.

Environmental Monitoring:

Viral testing and contact tracing are important factors in determining the spread of SARS-CoV-2 in communities. However, our understanding of how the virus is transmitted and spread is still growing.

Projects studying the transmission of the virus through the air in enclosed areas, and the detection of dead viral particles in wastewater to monitor pending outbreaks in a community are among some of the environmental monitoring projects ongoing on HudsonAlpha’s campus.

The strength of HudsonAlpha lies in the culture of collaboration and a unique structure that encourages entrepreneurship. That strength is currently being demonstrated through the research and development of diagnostic and treatment tools to combat COVID-19. Companies among those on the HudsonAlpha campus working to combat this disease:

Partnered with multiple entities for outreach efforts in ethnic and racial minority communities disproportionately affected by COVID-19. Acclinate engaged and educated trial participants and biotech researchers to reduce underrepresentation and lead to better and safer medication.

Alimetrix is a molecular diagnostic laboratory providing PCR testing to identify the Covid-19 live virus.

Working on various aspects of COVID-19 respiratory viral infection, transmission, protection and treatment.

Providing testing for COVID-19 with molecular testing panel that not only detects the virus that causes COVID-19, but also five bacterial pathogens associated with respiratory complications in high risk patients.

Continues to support the advancement of COVID-19 diagnostic testing and vaccine development by providing expert biospecimen solutions, genomic, immunohistochemistry and flow cytometry services.

Launched “Burl Gives Back” to address food insecurity due to the stay-at-home restrictions. The company is donating one bag of its Burl Barley Granola® product for every four bags of granola sold.

Foresight Biosciences has human cell-expressed both the receptor-binding domain (RBD) of the COVID-19 spike protein and angiotensin-converting enzyme 2 (ACE-2) for general research and commercial use.

Developed a fully automated, random access system for the rapid detection of infectious pathogens, including COVID-19.

Developed a technology that could collect the antibodies from patients who have recovered from COVID-19 and produce them in large quantities to then be used for treating patients with active disease.

Engineered a reagent critical to pathogen detection testing. This reagent was difficult to source during the early stages of the pandemic, limiting the number of tests available to the public. iXpressGenes worked quickly to optimize the manufacturing process to help diagnostic companies meet demand.

Developing affordable, non-invasive, routine screening of populations to identify infected individuals including those that are pre-symptomatic and asymptomatic to make workplaces and schools safer.

Performing human diagnostics, manufacturing COVID-19 diagnostic products and developing COVID-19 assays.

Prozone Water Products has published the results of a study investigating the use of UV radiation and ozone treatments as a possible disinfectant for n95 masks.

Supplying reagents to researchers working on COVID-19.

June 30, 2020
June 30, 2020 (Huntsville, Ala.) – Everbloom Health, Inc., a Sulfilatec company, has launched a new program called “Burl Gives Back” to address food insecurity. Through this program, the company is donating one bag of its ...
June 3, 2020
As most summer camps and educational opportunities have been canceled due to the COVID-19 pandemic, the HudsonAlpha Institute for Biotechnology is helping students, educators and the public continue learning with online opportunit...
May 21, 2020
Alabama Governor Kay Ivey recently awarded HudsonAlpha and Auburn University $2.27 million through the Alabama Research and Development Enhancement Fund. The fund was established to encourage new and continuing efforts to conduc...
May 18, 2020
On May 7, WLRH launched a new radio series, the “New Normal,” for stories on how our community is seeking the balance between staying healthy and welcoming back business. Neil Lamb, PhD, joined local organizations to d...
May 18, 2020
HudsonAlpha President and Science Director Rick Myers, PhD, spoke with about how safely reopening Alabama’s schools, universities and workplaces in the coronavirus pandemic means screening everyone who enters their build...
May 14, 2020
The iC-COVID19 Assay™ expands coronavirus testing May 14, 2020 (Huntsville, Ala.) – iCubate®​ ​, provider of accurate and affordable syndromic diagnostic testing, announces the launch of the iC-COVID19 Assay™. As the ...
May 11, 2020
While the world continues its fight against novel coronavirus, researchers and private industry have banded together in order to slow the spread of the virus and develop new tests and treatments for COVID-19. Now, more than ever, ...
May 7, 2020
Researchers at the HudsonAlpha Institute for Biotechnology are continuing to study virus-fighting antibodies from COVID-19 survivors in hopes of soon developing a cure. Rick Myers, PhD, spoke with WAFF about how researchers will u...
May 1, 2020
HudsonAlpha resident associate company Diatherix-Eurofins announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its SARS-CoV-2 assay. Click here to read the full announcement. Diat...
May 1, 2020
HudsonAlpha President and Science Director Rick Myers, PhD, gives an update on coronavirus research and support happening on our campus. This update includes work done through our non-profit research labs as well as through the as...
May 1, 2020
Huntsville Hospital, HudsonAlpha and iRepertoire, Inc., announced this week a collaborative study to develop a treatment for COVID-19. Institute and company leaders spoke with local media about how they will utilize local patients...
April 29, 2020
HudsonAlpha is responding to the COVID-19 pandemic by deploying new research projects to study the disease. A matching gift challenge for #GivingTuesdayNow will kick-start the campaign to raise funds for new research into COVID-19...
April 29, 2020
Huntsville Hospital, HudsonAlpha and iRepertoire, Inc. are studying local patients diagnosed with COVID-19 under a Huntsville Hospital IRC approved protocol to learn how the human immune system responds to the SARS-CoV-2 virus.
April 14, 2020
Two Huntsville Based Companies Joining Forces to Solve a Tough Problem April 14, 2020 (Huntsville, Ala.) – The COVID-19 pandemic has brought a long-standing problem to the forefront – racial and ethnic disparities in healthca...
March 25, 2020
In an effort to continue keeping the public informed about COVID-19, the HudsonAlpha Institute for Biotechnology has launched a series of educational videos to help separate fact from myth about the virus. 
March 18, 2020
The recent coronavirus disease (COVID-19) outbreak presents enormous challenges for global health. However, there are innovative projects underway at HudsonAlpha Institute for Biotechnology contributing to the global fight against...